Dermagraft

human fibroblast-derived dermal substitute · Shire Regenerative Medicine

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Dermagraft, covering 2013-02-04 to 2018-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers [Phase 3]